ACUTA CAPITAL PARTNERS, LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 156 filers reported holding KURA ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$6,403,088
-14.7%
702,093
-1.0%
4.29%
-15.6%
Q2 2023$7,502,468
+8.5%
709,118
+25.5%
5.08%
-0.2%
Q1 2023$6,913,093
+11.1%
565,257
+12.7%
5.09%
+33.0%
Q4 2022$6,223,615
-15.1%
501,500
-6.5%
3.83%
+21.4%
Q3 2022$7,329,000
-25.5%
536,5000.0%3.16%
-42.4%
Q2 2022$9,834,000
+29.0%
536,500
+13.2%
5.48%
+53.9%
Q1 2022$7,621,000
+86.5%
473,969
+62.4%
3.56%
+107.4%
Q4 2021$4,086,000
-25.3%
291,8840.0%1.72%
-11.0%
Q3 2021$5,467,000
-25.8%
291,884
-17.4%
1.93%
-34.5%
Q2 2021$7,368,000
-51.4%
353,398
-34.2%
2.94%
-46.2%
Q1 2021$15,176,000
-27.1%
536,820
-15.8%
5.47%
-3.4%
Q4 2020$20,821,000
-30.2%
637,500
-34.5%
5.67%
-30.0%
Q3 2020$29,813,000
+109.6%
973,000
+11.5%
8.10%
+97.0%
Q2 2020$14,222,000
+621.9%
872,500
+340.7%
4.11%
+330.3%
Q1 2020$1,970,000
-40.3%
198,000
-17.5%
0.96%
+16.9%
Q4 2019$3,300,000
+129.0%
240,000
+152.6%
0.82%
-21.4%
Q3 2019$1,441,00095,0001.04%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 206,307$3,363,00011.31%
Foresite Capital Management IV, LLC 1,307,982$21,320,00010.39%
EcoR1 Capital, LLC 4,608,529$75,119,0005.55%
Prosight Management, LP 685,000$11,166,0004.79%
ACUTA CAPITAL PARTNERS, LLC 872,500$14,222,0004.11%
BVF INC/IL 2,775,882$45,247,0002.79%
VR Adviser, LLC 575,000$9,373,0002.24%
ALETHEA CAPITAL MANAGEMENT, LLC 216,171$3,524,0002.06%
DAFNA Capital Management LLC 294,260$4,796,0001.38%
Vivo Capital, LLC 1,050,000$17,115,0001.23%
View complete list of KURA ONCOLOGY INC shareholders